Delivery Order SPE2DR25D2104-SPE2DR26F3VCY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,079.08 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-packs) on January 7, 2026, with an ultimate completion date of January 8, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a $1,023.31 delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Epinephrine 0.15 mg auto-injector 2-packs. This competitively awarded, firm fixed-price delivery order is scheduled for completion by January 13, 2026, with performance at the contractor's Conshohocken, Pennsylvania facility. The contract represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of epinephrine 0.3 mg auto-injector packs (two-count units) with a ceiling value of $1,923.88. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania, and scheduled for completion by January 23, 2026. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs valued at $2,954.20. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 17, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $2,264.83 and an ultimate completion date of January 15, 2026. This non-set-aside contract was competitively awarded and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999.999 billion through December 2026),...
- The Defense Logistics Agency awarded a $5,625.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of epinephrine 0.3 mg auto-injector kits (2-packs). This competitive award, which carries an ultimate completion date of January 13, 2026, represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. The delivery will be fulfilled from the...
- The Defense Logistics Agency awarded a $3,081.23 delivery order to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of Epinephrine 0.3 mg auto-injector two-packs. This firm fixed-price contract, with a completion date of January 20, 2026, was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's parent company Cencora, Inc.'s...
- The Defense Logistics Agency awarded a delivery order valued at $2,327.58 to AmerisourceBergen Drug Corp for Epinephrine 0.3 mg auto-injector (2-pack) on November 3, 2025, with completion scheduled for November 4, 2025. This competitively awarded, firm fixed price delivery order represents a small-value transaction from AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work...
- The Defense Logistics Agency awarded a delivery order valued at $10,822.86 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector two-packs. The contract was awarded on January 13, 2026, with an ultimate completion date of January 14, 2026, and is structured as a firm fixed-price delivery order with no set-aside designation. Performance will be executed at the awardee's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $13,330.12 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.15 mg auto-injectors (2-pack configuration) on January 20, 2026, with an ultimate completion date of January 21, 2026. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3VCYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,515.76 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs on February 4, 2026, with an ultimate completion date of February 5, 2026. The contract utilizes firm fixed-price pricing with no set-aside designation, indicating full and open competition. Performance will be executed from the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract vehicle—the DLA Troop Support Medical Pharmaceutical Prime Vendor Global Program contract—valued at up to $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The company maintains a comprehensive portfolio of pharmaceutical products and medical supplies available through its DLA contract, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This particular delivery order for epinephrine auto-injectors supports critical emergency medical supply requirements for military treatment facilities and other federal healthcare institutions.